A never ending story.

Dreams. Imagination. Knowledge. Dedication. Reality.

2010
30/03/2010

Start

In March 2010 Echolight srl was officially incorporated by the founding team with a revolutionary idea: developing the first radiation free device for early diagnosis of osteoporosis at lumbar vertebrae and femoral neck.
2011
30/05/2011

Patent

It is officially filed the first patent of EchoSound technology: an innovative echographic approach for bone micro-architecture characterization.
14/06/2011

Life Science Capital

Life Science Capital S.p.a., an italian investment company in the medical device sector, invests in Echolight to support and speed up the research and development activities of the company.
2012
25/11/2012

EchoS

The first version of Echos is finalized: the only radiation free device for bone densitometry at lumbar vertebrae and femoral neck. A decisive step towards a new era in the early diagnosis of osteoporosis.
2013
15/12/2013

Clinical Trials

In collaboration with the National Council of Research the first multi-center study for the clinical validation of the new device in the most important reference centers for the diagnosis of osteoporosis is launched.
2014
20/10/2014

Certifications

Echolight secured all the standard certifications: UNI CEI EN ISO 13485: 2012, ISO 13485: 2003, UNI EN ISO 9001: 2008 Quality Management System and the CE mark for Echos, EchoStation and EchoStudio by KIWA CERMET.
2015
29/04/2015

Premiere

Echolight introduces to the international medical community the latest release of Echos at the World Congress of Osteoporosis.
2016
21/07/2016

Investment Round

Panakès and Invitalia Ventures have co-led an investment round in Echolight, in order to support the clinical validation of the innovative technology and the worldwide launch of the product.
18/11/2016

Market Launch

Echolight at the International Trade Fair MEDICA launched Echos after extensive research and development activities carried out over the last eight years.
2017
28/01/2017

Advisory Board

Echolight established the new international scientific advisory board with the most important medical personalities in the diagnosis of osteoporosis : Prof. Maria Luisa Brandi, Prof. Cyrus Cooper, Prof. Adolfo Diez-Perez, Prof. Jean-Yves Reginster and Prof. Renè Rizzoli.
2018
02/08/2018

R.E.M.S Multicenter Clinical Trial

Milestone pubblication on Osteoporosis International about R.E.M.S. Multicenter Clinical Trial: "Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck."
19/10/2018

FDA clearence

Echolight S.p.A. has received 510(k) clearance from the Food and Drug Administration (FDA) to market its range of products in the U.S.A.